Healthcare -
Biotechnology - NASDAQ - US
$ 30.75
-0.646 %
$ 13.7 B
Market Cap
12.11
P/E
Price Target
Average
46.34%
Revenue Forecast
Estimate
23.12%
EBIT
Estimate
26.70%
Net Income
Estimate
52.53%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Royalty Pharma plc
Wall Street analysts predict an average 1-year price target for RPRX of $45 , with forecasts ranging from
a
low of
$28 to a high of $51 .
RPRX Lowest Price Target
Wall Street Target
28 USD
-8.94%
RPRX Average Price Target
Wall Street Target
45 USD
46.34%
RPRX Highest Price Target
Wall Street Target
51 USD
65.85%
REVENUE FORECAST
Revenue Forecast Chart RPRX
EBIT FORECAST
EBIT Forecast Chart RPRX
NET INCOME FORECAST
Net Income Chart RPRX